Učitavanje...
Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
BACKGROUND: Belatacept was approved for prevention of acute rejection in adult kidney transplantation in 2011 based on two randomized, controlled, multicenter phase 3 studies. Long-term experience over 10 years with belatacept-based immunosuppression after kidney transplantation has not been reporte...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elmer Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3935530/ https://ncbi.nlm.nih.gov/pubmed/24578751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr1697w |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|